Treatment of osteoporosis with vitamin D

Osteoporosis International

Volumn 7, Issue SUPPL. 3, 1997, Pages

  Kanis, J A ^a   McCloskey, E V ^a   De Takats, D ^a   Bernard, J ^a   Zhang, D M ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALFACALCIDOL; CALCITRIOL; CALCIUM; PARATHYROID HORMONE; VITAMIN D;

BONE MASS; CALCIUM BLOOD LEVEL; CONFERENCE PAPER; DIET SUPPLEMENTATION; ELDERLY CARE; FRACTURE; HUMAN; HYPERCALCEMIA; KIDNEY CALCIFICATION; KIDNEY INJURY; OSSIFICATION; OSTEOPOROSIS; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM;

BONE DENSITY; CALCITRIOL; CHOLECALCIFEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; ERGOCALCIFEROLS; FEMALE; FRACTURES, SPONTANEOUS; HUMANS; HYDROXYCHOLECALCIFEROLS; HYPERCALCEMIA; OSTEOPOROSIS, POSTMENOPAUSAL; SPINAL FRACTURES; VITAMIN D;

EID: 0031467060     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03194360     Document Type: Article

References (53)

1. Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, DeLuca HF. Intestinal absorption of serum vitamin D metabolites in normal subjects and osteoporosis patients: effect of age and dietary calcium. J Clin Invest 1979;64:729-36.
2. Kanis JA. Textbook of osteoporosis. Oxford: Blackwell Science, 1996.
3. Lips P, Wiersinga A, van Ginkel FC, Jongen MJM, Netelenbos JC, Hackeng WHL, et al. The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. J Clin Enocrinol Metab 1988;67:644-50.
4. 3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992;327:1637-42.
5. Lips P. Netelenbos JC, Jongen MJM, et al. Histomorphometric profile and vitamin D status in patients with femoral neck fractures. Metab Bone Dis Rel Res 1982;4:89-93.
6. Kanis JA, McCloskey EV, Beneton MNC. Vitamin D and analogues in renal bone disease and implications for osteoporosis. Osteoporos Int 1997;7(Suppl 3).
7. Nordin BEC, Need AG, Morris HA, Horowitz M, Robertson WG. Evidence for a renal calcium leak in postmenopausal women. J Clin Endocrinol Metab 1991;72:401-7.
8. 3 on calcium balance and bone turnover and its effects on vertebral fracture rate. Metabolism 1990;4(Suppl 1):30-4.
9. Caniggia A, Nuti R, Lore F, Martini G, Turchetti V, Righi G. Long-term treatment with calcitriol in postmenopausal osteoporosis. Metabolism 1990;4:(Suppl 1):43-9.
10. 3 stimulates osteoblasts but not osteoclasts in osteoporosis and osteoarthritis. Calcif Tissue Int 1991;49:168-73.
11. 3 administration raises serum osteocalcin in patients with postmenopausal osteoporosis. J Clin Endocrinol Metab 1985;60:615-7.
12. Need AG, Nordin BEC, Horowitz M, Morris HA. Calcium and calcitriol therapy in osteoporotic postmenopausal women with impaired calcium absorption. Metabolism 1990;4(Suppl 1):53-4.
13. 3: short and long term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis. Proc Natl Acad Sci USa 1982;79:3325-9.
14. Gallagher JC, Goldgar D. Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol: a randomised controlled study. Ann Intern Med 1990;113:649-55.
15. Ott S, Chestnut CH. Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann Intern Med 1989;110:267-74.
16. 3 with and without oestrogens on calcium balance in postmenopausal women. Clin Endrocinol 1977;7(Suppl 23):159-68.
17. Christiansen C, Christensen MS, McNair P, Hagen C, Stocklund F, Transbol I. Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur J Clin Invest 1980;10:273-9.
18. 3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis. Eur J Clin Invest 1981;11:305-9.
19. 3 and calcium. Clin Endocrinol 1982;16:515-24.
20. Aloia JF, Waswani A, Yeh JK, Ellis K, Yasumura S, Cohn SH. Calcitriol in the treatment of postmenopausal osteoporosis. Am J Med 1988;84:401-8.
21. 3 and muscle strength in the elderly: a randomized controlled trial. J Clin Endocrinol Metab 1991;73:1111-7.
22. 3) on osteoporosis: multicenter double-blind study. J Clin Exp Med 1982;123:958-73.
23. Fujita T, Matsui T, Nakao Y, Shiozawa S, Imai Y. Cytokines and osteoporosis. Ann N Y Acad Sci 1990;587:371-5.
24. Hoikka V, Ahlava EM, Aro A, Karjalainen P, Rehnberg V. Treatment of osteoporosis with 1-alpha-hydroxycholecalciferol and calcium. Acta Med Scand 1980;207:221-4.
25. Falch JA, Odeggard OR, Finnanger AM, Matheson I. Postmenopausal osteoporosis: no effect of three years treatment with 1,25-dihydroxycholecalciferol. Acta Med Scand 1987;221:199-204.
26. Gallagher JC, Riggs BL, Recker RR, Goldgar D. The effect of calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency. Proc Soc Exp Biol Med 1989;191:287-92.
27. Nordin BEC, Baker MR, Horsman A, Peacock M. A prospective trial of the effect of vitamin D supplementation on metacarpal bone loss in elderly women. Am J Clin Nutr 1985;42:470-4.
28. Fujita T. Studies of osteoporosis in Japan. Metabolism 1990; 4(Suppl 1):39-42.
29. Nordin BEC. Nutritional considerations. In: Nordin BEC, editor. Calcium, phosphate and magnesium metabolism. Edinburgh: Churchill Livingstone, 1976:1-35.
30. 3 and intestinal vitamin D receptor concentrations in normal women. J Clin Endocrinol Metab 1992;75:176-82.
31. Francis RM, Peacock M, Taylor GA, Stoner JH, Nordin BEC. Calcium malabsorption in elderly women with vertebral fracture: evidence for resistance to the action of vitamin D metabolites on the bowel. Clin Sci 1984;66:103-7.
32. Tilyard M, Spears GFS, Thomson J, Dovey S. Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 1992;326:357-62.
33. 3 accelerate spinal bone loss? A controlled therapeutic trial in 70-year-old women. Clin Orthop 1985;192:215-21.
34. 3 and low dose intermittent elcatonin (eel calcitonin derivative). J Bone Miner Metab 1992;10:37-40.
35. 3. Bone Miner 1987;3:47-52.
36. 3. J Bone Miner Metab 1992;10:50(184)-54(188).
37. 3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. Calcif Tissue Int 1994;54:370-6.
38. Kanis JA, Johnell O, Gullberg B, Allander E, Dilzen G, Gennari C, et al. Evidence for the efficacy of bone active drugs in the prevention of hip fracture. BMJ 1992;305:1124-8.
39. 3). Endo crinol Jpn 1985;32:305-15.
40. 3: a three-year prospective study. Clin Rheumatol 1992;11:492-7.
41. 3 and renal function. Acta Med Scand 1982;211:51-4.
42. Tvedegaard E, Madsen S. Alphacalcidol and renal function in normal subjects. Miner Electrolyte Metab 1988;14:158-62.
43. 3 on renal function in normal subjects. Metab Bone Dis Rel Res 1981;2:297-9.
44. Fonseca V, Mohiuddin J, Weerakoon J, Boss M, Mikhailidis DP, Danidona P. Plasma creatinine and creatinine clearance in nutritional osteomalacia. Lancet 1984;I:1093-5.
45. Naik RB, Cundy T, Robinson BHB, Russell RGG, Kanis JA. Effects of vitamin D metabolites and analogues on renal function. Nephron 1981;28:17-25.
46. Hamdy NAT, Kanis JA, Beneton MNC, Brown CB, Juttman JR, Jordans JGM, et al. Effect of alfacalcidol on the natural course of renal bone disease in mild to moderate renal failure. BMJ 1995;310:358-63.
47. Kanis JA, Russell RGG. Rate of reversal of hypercalcaemia induced by vitamin D3 and its 1μ-hydroxylated derivatives. BMJ1977;I:78-81.
48. Dawson-Hughes B, Dallai GE, Krall EA, Harris S, Sokoll LJ, Falconer G. Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann Intern Med 1991:115:505-12.
49. Chapuy MC, Arlot ME, Delmas PD, Meunier PJ. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 1994;308:1081-2.
50. Heikinheimo RJ, Inkovaara JA, Harju EJ, Haavisto MV, Kaarela RH, Kataja JM, et al. Annual injection of vitamin D and fractures of aged bones. Calcif Tissue Int 1992;51:105-10.
51. Lips P. Vitamin D deficiency and osteoporosis: the role of vitamin D deficiency and treatment with vitamin D and analogues in the prevention of osteoporosis-related fractures. Eur J Clin Invest 1996;26:436-42.
52. Ranstam J, Kanis JA. Influence of body mass on the effects of vitamin D on hip fracture risk. Osteoporos Int 1995;5:450-4.
53. Torgerson DJ, Kanis JA. Cost-effectiveness of preventing hip fractures in the elderly population using vitamikn D and calcium. QJM 1995;88:135-9.